|
|
|
|
||
Re: Institutional Ownership"I used to own both but simufilam data release last made me change my mind about Cassava" Not me--I am still feeling pretty good about SAVA's prospects although I do have questions about the duration of effective treatment. Even if the drug only maintains cognitive stability for one year, that will easily justify regulatory approval. |
return to message board, top of board |